Trial intelligence / Profile preview

Topical TwHF Gel for Moderate Rheumatoid Arthritis

NCT02818361Completed

Sponsor
Guang'anmen Hospital
Start
Apr 2012
Primary completion
Mar 2013
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial in rheumatoid arthritis (RA) comparing topical TwHF gel group with placebo group (2 arms). Primary endpoint: American College of Rheumatology 20% improvement at 8 weeks. Started Apr 2012; status: completed.

02

Drugs

Tripterygium wilfordii
03

Conditions

rheumatoid arthritis (RA)

Beyond the preview

Go deeper on NCT02818361.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02818361.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call